A HISTORY OF INFLAMMATORY BOWEL DISEASE (IBD) IS ASSOCIATED WITH A REDUCED RISK OF REQUIRING LIVER TRANSPLANT AMONGST PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS (PSC)

被引：0
|
作者：
Ridout, Nicholas [1 ]
Huh, Alex [1 ]
Morrison, D. Alexander [1 ]
Daaboul, Yazan [1 ]
Karagozian, Raffi [1 ]
机构：
[1] Tufts Med Ctr, Boston, MA 02111 USA
来源：
HEPATOLOGY | 2019年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1304
引用
收藏
页码：792A / 792A
页数：1
相关论文
共 50 条
  • [21] Colonoscopy Surveillance in Liver Transplant Recipients for Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease
    Rzadkowski, Stanislaw
    Chmielinska, Agnieszka
    Pacholczyk, Marek
    Lagiewska, Beata
    TRANSPLANTATION PROCEEDINGS, 2020, 52 (08) : 2484 - 2486
  • [22] Efficacy and Safety of Anti-TNF Therapy for Inflammatory Bowel Disease (IBD) in Liver Transplant Recipients for Primary Sclerosing Cholangitis (PSC): A Multicenter Experience
    Combes, Roman
    Altwegg, Romain
    Laharie, David
    de Ledinghen, Victor
    Radenne, Sylvie
    Conti, Filomena
    Chazouilleres, Olivier
    Duvoux, Christophe
    Peyrin-Biroulet, Laurent
    Dumortier, Jerome
    Leroy, Vincent
    Treton, Xavier
    Durand, Francois
    Dharancy, Sebastien
    Nachury, Maria
    Goutorbe, Felix
    Lamblin, Geraldine
    Pageaux, Georges-Philippe
    GASTROENTEROLOGY, 2015, 148 (04) : S865 - S865
  • [23] Risk of Colorectal Cancer With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis Compared to Primary Sclerosing Cholangitis Only: A Need for Consensus on Colonoscopy Surveillance Guidelines for PSC Without IBD
    Das, Taranika Sarkar
    Ho, Kimberly
    Udaikumar, Jahnavi
    Chen, Bryan
    Delau, Olivia
    Shaukat, Aasma
    Jacobson, Ira
    Sarwar, Raiya
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1195 - S1197
  • [24] Inflammatory bowel disease (IBD) is a risk factor for extrahepatic cholangiocarcinoma (ECC) in subjects without underlying primary sclerosing cholangitis (PSC)
    Ghoz, Hassan M.
    Baichoo, Esha
    Addissie, Benyam D.
    Roberts, Lewis R.
    Chaiteerakij, Roongruedee
    HEPATOLOGY, 2014, 60 : 852A - 852A
  • [25] VEDOLIZUMAB IS NOT ASSOCIATED WITH INCREASED INFECTION RISK IN IMMUNOSUPPRESSED LIVER TRANSPLANT RECIPIENTS WITH INFLAMMATORY BOWEL DISEASE AND PRIMARY SCLEROSING CHOLANGITIS
    Tse, Chung Sang
    Loftus, Edward V.
    Raffals, Laura H.
    Lightner, Amy L.
    GASTROENTEROLOGY, 2019, 156 (06) : S636 - S636
  • [26] LACK OF EFFICACY OF INFLIXIMAB (IFX) IN THE TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS (PSC) IN INFLAMMATORY BOWEL DISEASE (IBD) IN CHILDHOOD
    Cardile, S.
    Candusso, M.
    Papadatou, B.
    Knafelz, D.
    Bracci, F.
    Pietrobattista, A.
    Liccardo, D.
    Torre, G.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 : E255 - E255
  • [27] COEXISTENCE OF INFLAMMATORY BOWEL DISEASE (IBD) AND PRIMARY SCLEROSING CHOLANGITIS (PSC) IN CHILDREN: A CLINICAL AND PATHOGENETIC INTRIGUED MODEL
    Cardile, S.
    Candusso, M.
    Papadatou, B.
    Knafelz, D.
    Bracci, F.
    Pietrobattista, A.
    Liccardo, D.
    Torre, G.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 : E255 - E256
  • [28] Efficacy and safety of anti-TNF therapy for inflammatory bowel disease (IBD) in liver transplant recipients for primary sclerosing cholangitis (PSC): a multicenter experience.
    Combes, R.
    Altwegg, R.
    Laharie, D.
    De Ledinghen, V.
    Radenne, S.
    Conti, F.
    Chazouilleres, O.
    Duvoux, C.
    Peyrin-Biroulet, L.
    Dumortier, J.
    Leroy, V.
    Treton, X.
    Durand, F.
    Dharancy, S.
    Nachury, M.
    Goutorbe, F.
    Lamblin, G.
    Pageaux, G. -P.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S40 - S40
  • [29] The Types of Inflammatory Bowel Disease (IBD) Predispose to Distinct Clinical Phenotypes of Primary Sclerosing Cholangitis (PSC) in Children
    Jones, Keaton R.
    Bufler, Philip
    Miethke, Alexander G.
    GASTROENTEROLOGY, 2014, 146 (05) : S928 - S929
  • [30] Inflammatory bowel disease course in liver transplant versus non-liver transplant patients for primary sclerosing cholangitis: LIVIBD, an IG-IBD study
    Ribaldone, Davide Giuseppe
    Imperatore, Nicola
    Le Grazie, Marco
    Furfaro, Federica
    Balestrieri, Paola
    De Blasio, Federico
    Fagoonee, Sharmila
    Mosso, Elena
    Boano, Valentina
    Reggio, Dario
    Sarli, Ennio
    Castiglione, Fabiana
    Milla, Monica
    Vecchi, Maurizio
    Saracco, Giorgio Maria
    Salizzoni, Mauro
    Romagnoli, Renato
    Fiorino, Gionata
    Astegiano, Marco
    DIGESTIVE AND LIVER DISEASE, 2021, 53 (06) : 712 - 716
12345